BREAKING NEWS
This content is not available in your region

Consort Medical agrees to 505 million pound buyout by Sweden's Recipharm

Access to the comments Comments
Text size Aa Aa

(Reuters) – Consort Medical Plc <CSRT.L> on Monday said Sweden’s Recipharm AB <RECIb.ST> would buy the London-listed healthcare company for 1,010 pence per share in cash.

Consort said the offer represented a premium of 39.1% to Friday’s close of 726 pence, valuing the company at about 505 million pounds ($646.20 million) on a fully diluted basis.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.